CHEMOTHERAPY AND G-CSF PRIMED PERIPHERAL-BLOOD CD34 POSITIVE STEM-CELLS WHICH PROVIDE HEMATOPOIETIC RECONSTITUTION AFTER HIGH-DOSE CHEMOTHERAPY CONTAIN A SUBSET OF HLA-DR NEGATIVE, CD38 NEGATIVE CELLS

被引:0
作者
MAHARAJ, D [1 ]
RILEY, R [1 ]
ONEILL, GJ [1 ]
PHILLIPS, J [1 ]
ELIA, J [1 ]
机构
[1] UNIV MIAMI,SCH MED,DEPT MICROBIOL IMMUNOL,DIV HEMATOL ONCOL,BONE MARROW TRANSPLANT PROGRAM,MIAMI,FL 33152
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:A13 / A13
页数:1
相关论文
共 50 条
[21]   CIRCULATING CD34+ CELL LEVELS DETERMINED 30 MINUTES FOLLOWING INFUSION PREDICT HEMATOLOGIC RECOVERY AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELLS [J].
DHONDT, L ;
DUPRET, PH ;
ANDRE, M ;
GUILLAUME, TH ;
FEVENS, AM ;
HUMBLET, Y ;
DROMELET, A ;
CHATELAIN, B ;
LONGUEVILLE, J ;
SYMANN, M .
EXPERIMENTAL HEMATOLOGY, 1995, 23 (08) :754-754
[22]   TOTAL CD34+ CELL CONTENT AND CD34+CD33- SUBSET PREDICT TIME TO NEUTROPHIL AND PLATELET ENGRAFTMENT AND HOSPITAL DISCHARGE IN PATIENTS FOLLOWING HIGH-DOSE CHEMOTHERAPY (HDC) WITH PRIMED PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) [J].
PECORA, AL ;
BROCHSTEIN, JA ;
JENNIS, A ;
MICHELIS, M ;
GRAZIOSO, L ;
ZAHOS, K ;
ISAACS, RE .
BLOOD, 1994, 84 (10) :A88-A88
[23]   PROLIFERATIVE ACTIVITY OF BONE-MARROW VERSUS PERIPHERAL-BLOOD CD34-POSITIVE CELLS ON STEADY-STATE AND FOLLOWING CHEMOTHERAPY PLUS G-CSF [J].
DANOVA, M ;
ROSTI, V ;
MAZZINI, G ;
LOCATELLI, F ;
COMOLI, P ;
RICCARDI, A ;
CAZZOLA, M ;
ASCARI, E .
BLOOD, 1994, 84 (10) :A23-A23
[24]   Clearance kinetics of CD34+ cells from peripheral blood:: an independent predictor of hematologic recovery after high-dose chemotherapy and hematopoietic stem cell transplantation [J].
D'Hondt, L ;
Wuu, J ;
André, M ;
van Lerberghe, C ;
Guillaume, T ;
Feyens, AM ;
Humblet, Y ;
Dromelet, A ;
Chatelain, B ;
Longueville, J ;
Stewart, FM ;
D'Hondt, V ;
Symann, M .
BONE MARROW TRANSPLANTATION, 1999, 24 (05) :483-489
[25]   Clearance kinetics of CD34+ cells from peripheral blood: an independent predictor of hematologic recovery after high-dose chemotherapy and hematopoietic stem cell transplantation [J].
L D’Hondt ;
J Wuu ;
M André ;
C van Lerberghe ;
T Guillaume ;
A-M Feyens ;
Y Humblet ;
A Dromelet ;
B Chatelain ;
J Longueville ;
FM Stewart ;
V D’Hondt ;
M Symann .
Bone Marrow Transplantation, 1999, 24 :483-489
[26]   Infusion of CD34 enriched peripheral blood progenitor cells result in rapid engraftment after high-dose chemotherapy in patients with advanced lymphoma. [J].
Koc, ON ;
Gerson, SL ;
Fox, RM ;
Schupp, JE ;
Marko, DA ;
Steckley, JA ;
Lazarus, HM .
BLOOD, 1995, 86 (10) :917-917
[27]   RAPID HEMATOPOIETIC RECONSTITUTION FOLLOWING 3 CYCLES OF HIGH-DOSE CHEMOTHERAPY WITH FILGRASTIM (G-CSF)-MOBILIZED PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) AND FILGRASTIM IN PATIENTS WITH HIGH-RISK BREAST-CANCER [J].
BASSER, R ;
TO, B ;
GREEN, M ;
SZER, J ;
BAYLY, J ;
DUGGAN, G ;
BEGLEY, G ;
DYSON, P ;
FOX, R ;
COLLINS, J ;
RUSSELL, I ;
MAHER, D ;
CEBON, J ;
MARTY, J ;
JUTTNER, C ;
DZIEM, G ;
HOFFMAN, E ;
SHERIDAN, W .
BLOOD, 1993, 82 (10) :A233-A233
[28]   The dose of granulocyte colony-stimulating factor (G-CSF) administered in cancer patients post-chemotherapy is not related to the level of circulating CD34(+) hematopoietic stem cells. [J].
Martin, S ;
Voso, MT ;
Hohaus, S ;
Pforsich, M ;
Goldschmidt, H ;
Haas, R .
BLOOD, 1997, 90 (10) :925-925
[29]   Platelet recovery after high-dose (HD) chemotherapy (C) is superior with peripheral blood stem cells (PBSC) mobilized by C+G-CSF compared to G-CSF alone [J].
Crump, M ;
Yee, K ;
Imrie, K ;
Couban, S ;
Stewart, AK ;
Saragosa, R ;
Keating, A .
EUROPEAN JOURNAL OF CANCER, 1997, 33 :397-397
[30]   CD34+ CONCENTRATED PERIPHERAL-BLOOD STEM-CELLS (CPBSC) INFUSED AFTER HIGH-DOSE CHEMOTHERAPY (HDCT) RESULT IN EQUIVALENT HEMATOPOIETIC ENGRAFTMENT KINETICS AS COMPARED TO UNCONCENTRATED PBSC AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) [J].
ADKINS, D ;
BERENSON, R ;
BOWERS, C ;
BROUN, G ;
DUNPHY, F ;
KRONMUELLER, N ;
PETRUSKA, P ;
VELASQUEZ, W ;
SPITZER, G .
BLOOD, 1993, 82 (10) :A290-A290